A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

NCT01481051 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension (OH)

Interventions

DRUG: Latanoprost-PPDS

Sponsor

Mati Therapeutics Inc.